Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Morgan Stanley Maintains Axsome Therapeutics (AXSM) Equal-Weight Recommendation
Fintel reports that on April 12, 2023, Morgan Stanley maintained coverage of Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 78.83% Upside